Home

Sakar Healthcare Ltd PE Ratio

Image

Sakar Healthcare Ltd

NSE: SAKAR

PE

51

Last updated on: Jan 15, 2025

Key Highlights

  • The P/E Ratio of Sakar Healthcare Ltd is 51 as of 15 Jan 9.00 AM .
  • The P/E Ratio of Sakar Healthcare Ltd changed from 7.8 on March 2020 to 68.6 on March 2024 . This represents a CAGR of 54.47% over 5 years.
  • The Latest Trading Price of Sakar Healthcare Ltd is ₹ 290.45 as of 15 Jan 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 21.0 to 40.0 in 5 years. This represents a CAGR of 13.75%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.4. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 36.9 in 2024.

Historical P/E Ratio of Sakar Healthcare Ltd

No data available

Company Fundamentals for Sakar Healthcare Ltd

Image

Sakar Healthcare Ltd

NSE: SAKAR

Share Price

₹ 290.45

-0.50 (-0.17%)

stock direction

Last updated on: Jan 15, 2025

Market Price of Sakar Healthcare Ltd

1M

1Y

3Y

5Y

Monitoring Sakar Healthcare Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
15 Jan 2025290.45
14 Jan 2025290.95
13 Jan 2025291.4
10 Jan 2025294.55
09 Jan 2025294.7
08 Jan 2025297.35
07 Jan 2025297.85
06 Jan 2025298.15
03 Jan 2025303.1
02 Jan 2025303.35

SWOT Analysis Of Sakar Healthcare Ltd

Strength

2

che

Weakness

1

che

Opportunity

0

che

Threats

1

che

BlinkX Score for Sakar Healthcare Ltd

Asset Value vs Market Value of Sakar Healthcare Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
Sakar Healthcare Ltd631.73
Sun Pharmaceuticals Industries Ltd421527
Divis Laboratories Ltd156037
Cipla Ltd116854
Dr Reddys Laboratories Ltd111746

PE Ratio of Sakar Healthcare Ltd Explained

``

631.73

Market cap

12

Earnings

51.0X

PE Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Sakar Healthcare Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Sakar Healthcare Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Sakar Healthcare Ltd

No data available

* All values are in %

About Sakar Healthcare Ltd

  • Sakar Healthcare Limited was incorporated as a Private Limited Company under the name 'Sakar Healthcare Private Limited on 26th March 2004.
  • Subsequently, the Company was converted into Public Limited Company on March 27, 2015 and the name of the Company was changed to 'Sakar Healthcare Limited.
  • The Company is promoted by Sanjay Shah, Rita Shah and Aarsh Shah. The Company is engaged in manufacturing of Pharmaceutical products providing Liquid Orals, Cephalosporin Tablet, Capsule, Dry Powder Syrup, Dry Powder Injections, Liquid Injectables (SVP) in Ampoules and Vials & Lyophilized Injections and Oral Solid Dossages.
  • It manufactures and markets pharmaceutical formulations relating to analgesics, anti coagulants, anti malarial, anti spasmodic, antianemics, antibiotics, anti-emetics, anti-histamines, bronchodilators, corticosteroids, cough and cold preparations, multivitamins, etc.

Sakar Healthcare Ltd News Hub

Sakar Healthcare consolidated net profit declines 15.14% in the June 2024 quarter

Net profit of Sakar Healthcare declined 15.14% to Rs 2.41 crore in the quarter ended June 2024 as ag

Read more

13 Aug 2024

Sakar Healthcare to hold board meeting

Sakar Healthcare will hold a meeting of the Board of Directors of the Company on 13 August 2024. Pow

Read more

09 Aug 2024

Sakar Healthcare schedules board meeting

Sakar Healthcare will hold a meeting of the Board of Directors of the Company on 22 October 2024. Po

Read more

18 Oct 2024

Sakar Healthcare consolidated net profit rises 31.87% in the September 2024 quarter

Net profit of Sakar Healthcare rose 31.87% to Rs 4.80 crore in the quarter ended September 2024 as a

Read more

22 Oct 2024

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Sakar Healthcare Ltd

What is the current PE Ratio of Sakar Healthcare Ltd?

The Current PE Ratio of Sakar Healthcare Ltd is 50.96 as on 15 Jan 2025.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 15 Jan 2025.

What was the PE Ratio of Sakar Healthcare Ltd last year?

The PE Ratio of Sakar Healthcare Ltd was 29.94 last year, now the PE ratio is 50.96, showing a year-on-year growth of 70.2%.

What does the PE Ratio of Sakar Healthcare Ltd indicate about its stock?

The PE Ratio of Sakar Healthcare Ltd is 50.96. This ratio indicates that investors are willing to pay 50.96 times the earnings per share for each share of Sakar Healthcare Ltd.

What is the PE Ratio Growth of Sakar Healthcare Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Sakar Healthcare Ltd grew by 70.2% whereas, the EPS ratio grew by 97.3.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions